AstraZeneca Collaborates with Gendius to Provide Diabetes Management Support for Patients in the GCC

 AstraZeneca Collaborates with Gendius to Provide Diabetes Management Support for Patients in the GCC

Shots:

  • The collaboration is built on Gendius’ diabetes management platform, Intellin, which has 200,000+ downloads worldwide. With the partnership, AstraZeneca allows HCPs across the Gulf region to use Gendius’ Intellin to augment diabetes management for reducing the incidence of complications
  • The partnership is being implemented within the framework of AstraZeneca’s Emerging Markets Health Innovation Hubs initiative to bring digital, R&D and commercial industries within emerging countries for improving patients’ outcomes. Intellin is compatible with 150+ apps and connected health devices, ranging from Fitbit and Garmin devices, to more specialist blood glucose monitors and blood pressure cuffs
  • As a result of collaboration, HealthGATE platform and app to support diabetic patient care in the GCC, will be launched later this year. The HealthGATE app will work as a gateway between HCPs and patients, enabling collaboration for personalized care and the use of AI for better disease management

Click here, Click here to read full press release/ article | Ref: Gendius | Image: Gendius

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post